In the study conducted by Pawłowska et al., the plasma sPD-1 levels did not differ significantly between the different cancer stages, whereas with regard to sPD-1 concentration in peritoneal fluid, it was significantly higher in patients with stage III–IV cancer than in stage I–II patients [20]. The gene discussed is HOXD13; the disease is cancer.